Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanming Zhang

Showing results (411-420 of 459) with videos related to

Pageof 46
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2025
DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like TumorsLucy Wang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2008
Distinct microRNA expression profiles in acute myeloid leukemia with common translocationsZejuan Li, Jun Lu, Miao Sun, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2012
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemiaXi Jiang, Hao Huang, Zejuan Li, et al.
Signal Transduction and Targeted Therapy|April 20, 2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trialHong Wang, Qingyuan Wang, Shan Liu, et al.
Cell Reports|May 18, 2022
A highland-adaptation mutation of the Epas1 protein increases its stability and disrupts the circadian clock in the plateau pikaNa Liu, Hongni Tian, Ziqing Yu, et al.
Blood Advances|July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphomaDavid Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Signal Transduction and Targeted Therapy|April 8, 2022
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumorsDeli Song, Xudong Jia, Xincheng Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Pageof 46

Showing results (411-420 of 459) with videos related to

Sort By:
Pageof 46
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2025
DNA Methylation Profiling Classifies and Reveals Origin of Gynecologic Central Nervous System-Like TumorsLucy Wang, Varshini Vasudevaraja, Jonathan Serrano, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2008
Distinct microRNA expression profiles in acute myeloid leukemia with common translocationsZejuan Li, Jun Lu, Miao Sun, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Leukemia Research|May 29, 2017
Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic TrialsStephen A Strickland, Zhuoxin Sun, Rhett P Ketterling, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2012
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemiaXi Jiang, Hao Huang, Zejuan Li, et al.
Signal Transduction and Targeted Therapy|April 20, 2026
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trialHong Wang, Qingyuan Wang, Shan Liu, et al.
Cell Reports|May 18, 2022
A highland-adaptation mutation of the Epas1 protein increases its stability and disrupts the circadian clock in the plateau pikaNa Liu, Hongni Tian, Ziqing Yu, et al.
Blood Advances|July 30, 2020
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphomaDavid Sermer, Sabela Bobillo, Ahmet Dogan, et al.
Signal Transduction and Targeted Therapy|April 8, 2022
Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumorsDeli Song, Xudong Jia, Xincheng Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2017
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117Mikkael A Sekeres, Megan Othus, Alan F List, et al.
Pageof 46